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Purpose: The selective cyclooxygenase-2 inhibitor lumiracoxib
has been shown to reduce endoscopically detected ulcers and
ulcer complications in the upper gastrointestinal tract compared
with non-selective non-steroidal anti-inﬂammatory drugs. We in-
vestigated whether lumiracoxib would reduce small bowel injury
compared with naproxen plus omeprazole.
Methods: Healthy volunteers were randomized to receive lu-
miracoxib 100 mg once daily, naproxen 500 mg twice daily plus
omeprazole 20 mg once daily or placebo in a 16-day double-
blind, parallel-group study. Small bowel mucosal injury and in-
ﬂammation were assessed by video capsule endoscopy (VCE),
the lactulose:rhamnose permeability assessment, and the faecal
calprotectin test.
Results: Of 152 randomized subjects, 139 completed the study
with valid VCEs (lumiracoxib, n = 47; naproxen plus omepra-
zole, n = 45; placebo, n = 47). Compared with placebo, an
increased number of subjects on naproxen plus omeprazole
had small bowel mucosal breaks (77.8% vs 40.4%, P<0.001),
with increased permeability (P=0.023) and raised faecal calpro-
tectin (increase of 96.8 mg/kg vs 14.5 mg/kg placebo, P<0.001).
With lumiracoxib, 27.7% of subjects had small bowel mucosal
breaks (P=0.196 vs placebo;P<0.001 vs naproxen), there was
no increase in permeability (P=0.157 vs placebo;P=0.364 vs
naproxen) and no increase in faecal calprotectin (-5.7 mg/kg;
P=0.377 vs placebo; P<0.001 vs naproxen).
Conclusions: As assessed by three different measures, acute
small bowel injury on lumiracoxib treatment is less frequent than
with naproxen plus omeprazole and similar to placebo.
238
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Purpose: Matrix associated transplantation techniques aim to
improve autologous chondrocyte implantation as introduced by
Brittberg. At the Medical University of Vienna, Department of
Orthopedics Hyalograft C, a bio scaffold based on hyaluronan
was used for autologous chondrocyte transplantation.
Methods: 53 patients were treated with Hyalograft C in the knee
joint. 31 were male, 22 female, 50 had single defects, 3 had
multiple defects. Mean age at implantation was 32 SD 12 years,
mean defect size was 4.4 SD 1.9 cm2, the mean BMI was 24.5
SD 3.8. 41 cases showed defects on the medial femoral condyle
(MFC), 6 cases on the lateral femoral condyle (LFC). 2 had
patellar defects, 1 tibial, 1 MFC/LFC, 1 tibial/MFC and in one
case multiple defects on the MFC were treated.
The primary indication for Hyalograft concerned young patients
with stable ligaments, regular knee alignment and singular de-
fects with healthy adjacent cartilage. During the ﬁrst two years,
implantation was also performed in eight salvage cases.
A biopsy for cell culture was harvested during ﬁrst look
arthroscopy. Cell expansion and scaffold seeding was carried
out by FIDIA Advanced Biopolymers, Abano Terme, Italy. Im-
plantation was carried out in arthroscopy and in miniarthrotomy.
We used three knee scoring systems for clinical follow up: the
Lysholm Score, a modiﬁed Cincinnati Knee Score and the IKDC
Subjective Knee Form.
For MRI evaluation we used an isotrope fat-supressed 3D GRE
sequence on a 3.0 T MRI unit (Siemens, Tim Trio).
For statistical evaluation we used bivariate correlation analysis
and unpaired, two-tailed t-tests.
Results: Cumulative evaluation demonstrated an improvement
below the level of signiﬁcance of p<0.001 in all scores (Table 1).
Table 1. Mean ± SD cumulative outcome of various scores
Before surgery 5 years after implantation
Modiﬁed Cincinnati Score 2.7±1.4 7.1±2.4
IKDC Subjective Knee Form 40.5±19.2 66.1±18.9
Lysholm Score 57.6±16.9 85.0±19.4
MRI at ﬁve years was available in nine cases and demonstrated
repair tissue (RT) in situ in all patients. The ﬁlling grade was
complete in 5 patients, 4 had a ﬁlling grade over 50%. Integration
with surrounding cartilage was complete in all cases. RT surface
was intact in 6 patients, minor ﬁbrillations were found in 3 cases.
RT was homogenous in 6 cases. We found minor bone marrow
edema in 3 patients. Joint effusion was absent in all cases. A
representative example for good outcome is shown in Fig. 1.
Figure 1. Repair tissue (RT) on the dorsal aspect of the medial femoral condyle
5 years after implantation (white arrows) with a complete ﬁlling of the defect,
excellent integration with surrounding cartilage and intact RT surface, homoge-
nous RT signal as well as isointense signal intensity. The subject is an active
runner, routine training comprised 80 kilometers per week before a traumatic
lesion of the meniscus (black arrow) occurred.
Spearman’s rho of age and the clinical improvement in the
Lysholm Score after one year was -0.449 (p = 0.006).
7 of 8 salvage patients underwent a total replacement of the
knee joint due to persisting pain between 2 and 5 years after im-
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plantation. Graft failure occurred in 4 of 45 patients with primary
indication between 6 months and 5 years after implantation.
Conclusions: Young patients with singular defects and intact
adjacent cartilage, ligamentous stability and regular knee align-
ment proﬁt from treatment with Hyalograft. The clinical outcome
seems to be comparable to autologous chondrocyte implanta-
tion. Still, simpler surgery and lower morbidity can be considered
advantages of the technique.
Hyalograft C apparently is not suited for the treatment of salvage
cases.
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Purpose: Although many people suffer from pain and disability
due to hand osteoarthritis (OA), knowledge about progression
of hand OA and effective therapies to inﬂuence progression
are lacking. The purpose of the present study is to investigate
currently available outcome measures to assess their respon-
siveness in a series of patients with hand OA over a two year
follow-up.
Methods: Participants of the GARP (Genetics, ARthrosis and
Progression) study, an observational study in middle-aged pa-
tients with symptomatic familial OA at multiple sites, were fol-
lowed for two years. Patients with hand OA, deﬁned by the Amer-
ican College of Rheumatology criteria for clinical hand OA, or
the presence of structural abnormalities (multiple bony swellings
or radiological OA) in the hands, were included in the present
study. Pain intensity upon lateral pressure in the DIP, IP, PIP and
CMC 1 joints was graded on a four-point scale. Self-reported
hand pain and functional limitations were assessed with the pain
and function subscales of the Australian/Canadian Osteoarthritis
Hand Index (AUSCAN LK 3.0). Standardised radiographs of the
hands were obtained at baseline and after two years. Right and
left DIP joints, IP joints of the thumbs, PIP joints and CMC 1
joints were scored (0-3) for osteophytes and joint space narrow-
ing (JSN). Standardised response mean (SRM) estimates were
calculated.
Results: 172 of the 189 patients included at baseline (91%)
completed the two-year follow-up (mean age 60.5 years, 78.5%
women). Statistically signiﬁcant increases in pain intensity on
lateral pressure, AUSCAN pain and AUSCAN function scores oc-
curred over the relative short follow-up period of 2 years. SRMs
were 0.67, 0.25 and 0.23 for pain intensity, AUSCAN pain and
AUSCAN function scores respectively. Statistically signiﬁcant ra-
diological progression of hand OA was detected in approximately
20% of the patients over 2 years. Progression could be seen in
terms of JSN as well as osteophytes and occurred most often in
the PIP and DIP joints. The SRMs for radiological progression
was 0.34 and 0.35 for JSN total and osteophyte total scores
respectively. Furthermore, progression of osteophytes occurred
more often in women and middle-aged patients, and especially
in women in an early post-menopausal stage. Increases in hand
pain and functional limitation over the 2 year follow-up period
were not associated with radiological progression of hand OA.
Conclusions: This present study shows that clinical and radi-
ological disease status of patients with hand OA deteriorated
substantially over a relatively short follow-up period of two years.
These ﬁndings highlight the need for new therapies and provide
information on outcome assessment in hand OA that will be
needed for the design of future clinical trials.
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Purpose: Gender differences are known to exist in the frequency
of radiographic OA at individual joint sites, but few data exist on
gender differences in radiographic OA phenotypes in a multi-joint
context. We examined gender differences in hand, knee, hip, and
lumbosacral spine phenotypes in a genetic association study.
Methods: The Genetics of Osteoarthritis (GO) study is com-
posed of 2,154 White men and women cases with generalized
OA (deﬁned by the presence of radiographic hand OA in at least
3 joints across both hands, involving at least one distal inter-
phalangeal joint and at least 2 hand joint groups and without
metacarpophalangeal joint swelling in 2 or more joints) and con-
trols aged 57 years or older with no evidence of joint symptoms
or radiographic OA in hands (PA ﬁlm centered on 3rd MCP),
knees (PA view with Synaﬂex device), or hips (AP pelvis). Hand,
hip, and knee OA was deﬁned as Kellgren-Lawrence grades 2-4.
Spine OA was deﬁned as osteophyte grade 1-3 and disc narrow-
ing (1-3) at the same vertebral level, using the Burnett atlas.
We selected 1,989 individuals (561 men, 1,428 women) with
available hand, knee, hip, and lumbosacral spine (lateral view)
data for this analysis. Multiple logistic regression was used to
assess gender differences in phenotypic combinations of joint
involvement, controlling for age, body mass index (BMI), joint-
speciﬁc injury, and education.
Results: Mean age of the women and men was 69.2 (8.3) and
70.7 (7.6), respectively; mean BMI was 27.2 (5.2) in women and
28.3 (4.3) in men (both p ≤ 0.0001). Men had an average of 15.2
years of education compared to 14.0 for women (p <0.0001).
Two hundred ninety six individuals had no evidence of OA in any
joint site evaluated with no gender difference (15.5% women,
13.4% men). One hundred seventy two had OA in all 4 sites,
with women (9.8%) over twice as likely as men (5.7%) to have
4 sites with OA (adjusted Odds Ratio [aOR], 95% CI = 2.21
[1.19, 4.13]). Women were almost twice as likely as men to
have isolated hand OA (8.3% vs 4.3%, aOR = 1.85 [1.07, 3.19]),
but less likely to have isolated hip, knee, or spine OA (Table).
Women were also more likely to have hand OA in association
with other OA phenotypes and equally or less likely than men
to have combined large joint OA phenotypes in the absence of
hand OA (Table).
Conclusions: Phenotypic manifestations of OA vary by gender,
with hand OA and hand OA-associated multi-joint OA more
common in women than in men, and isolated or combined large
Odds Ratios for female gender and OA phenotypes adjusted for age, BMI, joint
injury, education
Phenotype Adjusted OR (95% CI)
Hand only 1.85 (1.07, 3.19)
Hip only 0.56 (0.33, 0.94)
Knee only 0.54 (0.28, 1.04)
Spine only 0.71 (0.50, 1.02)
Hand/hip 2.08 (1.0, 4.34)
Hand/knee 1.6 (0.76, 3.40)
Hand/spine 1.35 (0.82, 2.22)
Hip/knee 0.94 (0.44, 2.00)
Hip/spine 0.74 (0.43, 1.27)
Knee/spine 0.5 (0.29, 0.87)
Hand/hip/knee 1.13 (0.42, 3.02)
Hand/hip/spine 2.16 (1.08, 4.33)
Hand/knee/spine 1.55 (0.84, 2.87)
ALL 2.21 (1.19,4.13)
